Smith–Fineman–Myers syndrome

From WikiMD's WELLNESSPEDIA

(Redirected from Juberg Marsidi syndrome)

X-linked recessive

Smith–Fineman–Myers syndrome (SFMS) is a rare genetic disorder characterized by a combination of distinctive facial features, developmental delays, and other physical abnormalities. It is also known as Smith-Fineman-Myers syndrome or SFMS. The syndrome is named after the researchers who first described it.

Signs and Symptoms[edit]

Individuals with Smith–Fineman–Myers syndrome typically present with a range of symptoms, which may include:

Genetics[edit]

Smith–Fineman–Myers syndrome is believed to be inherited in an X-linked recessive pattern. This means that the gene responsible for the disorder is located on the X chromosome, and the condition is more commonly seen in males. Females who carry one copy of the mutated gene typically do not show symptoms but can pass the gene to their offspring.

Diagnosis[edit]

The diagnosis of Smith–Fineman–Myers syndrome is based on clinical evaluation, identification of characteristic physical findings, and genetic testing. Molecular genetic testing can confirm the diagnosis by identifying mutations in the gene associated with the syndrome.

Treatment[edit]

There is no cure for Smith–Fineman–Myers syndrome. Treatment is symptomatic and supportive, focusing on managing the individual symptoms and improving the quality of life for affected individuals. This may include:

Prognosis[edit]

The prognosis for individuals with Smith–Fineman–Myers syndrome varies depending on the severity of symptoms and the presence of associated health issues. Early intervention and supportive care can help improve outcomes and quality of life.

Related Pages[edit]

References[edit]


External Links[edit]

-


Medical condition





















Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.